Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

We performed a prospective study of circulating immune cell changes after stereotactic body radiotherapy (SBRT) in 50 early-stage NSCLC patients. We found no significant increase in CD8(+) cytotoxic T lymphocytes at first follow-up (the primary endpoint) but detected a significant increase in expand...

Descripción completa

Detalles Bibliográficos
Autores principales: Gkika, Eleni, Firat, Elke, Adebahr, Sonja, Graf, Erika, Popp, Ilinca, Radicioni, Gianluca, Lo, Simon S., Nestle, Ursula, Nicolay, Nils H., Niedermann, Gabriele, Duda, Dan G., Grosu, Anca-L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981559/
https://www.ncbi.nlm.nih.gov/pubmed/36864234
http://dx.doi.org/10.1038/s41698-023-00358-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981559/
https://www.ncbi.nlm.nih.gov/pubmed/36864234
http://dx.doi.org/10.1038/s41698-023-00358-z

Ejemplares similares